News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Unique Antibodies Open Path Toward New HIV Vaccines
Amanda B. Keener | Jan 27, 2017
A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.
Toward an Immunotherapy for Alzheimer’s Disease
Tanya Lewis | Jul 28, 2016
Targeting tau antibodies does not require effector function, researchers report.
Vaccines Protect Mice Against Zika Infection
Alison F. Takemura | Jun 29, 2016
Two different vaccines confer complete immunity for two months, researchers report.
Zika and Dengue Immunity: A Complex Relationship
Amanda B. Keener | Jun 28, 2016
Researchers examine the blood of people infected with dengue virus, finding a few Zika-neutralizing antibodies among mostly enhancing ones.
Antibody Maker Loses License Over Animal Welfare Violations
Jef Akst | May 23, 2016
The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.
Tasmanian Devil Antibodies Fight Cancer
Jef Akst | May 9, 2016
The proteins could be the key to stopping the transmissible facial tumor disease that is threatening the species.
Dengue Antibodies Enhance Zika Infection?
Tanya Lewis | Apr 28, 2016
Previous flavivirus infection could help explain the severity of symptoms in some people infected during the ongoing Zika outbreak, researchers report.
In Situ Antibodies
Jyoti Madhusoodanan | Feb 2, 2016
Compared with systemic injections, localized antibody therapies may be more effective for some indications.
Building Better Reagents
Jane McLeod, Paul Ko Ferrigno | Feb 1, 2016
Facing problems of inconsistent, time-consuming, and costly antibody production, some researchers are turning to alternatives to target specific proteins of interest, in the lab and in the clinic.
When the Flu Vax Fails
Jef Akst | Dec 16, 2015
The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study.